REGISTRATION DOCUMENTATION AND AMENDMENTS TO IT AS AN ELEMENT OF A QUALITY MANAGEMENT SYSTEM IN PRODUCTION OF ANTI-RABIES IMMUNOGLOBULIN (REVIEW)

Introduction. Documentation is an integral part of the quality management system, a key element of production and quality control of medicines. A necessary condition for the Rules of good manufacturing practice and guaranteed production of quality products is compliance with the requirements set out...

Full description

Bibliographic Details
Main Authors: O. A. Lobovikova, I. V. Shul'gina, E. G. Abramova, A. K. Nikiforov, A. V. Komissarov, V. A. Demchenko, A. G. Selezneva, A. S. Fes'kova, S. S. Galetova, N. P. Mironova
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-02-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/653
_version_ 1797874994951225344
author O. A. Lobovikova
I. V. Shul'gina
E. G. Abramova
A. K. Nikiforov
A. V. Komissarov
V. A. Demchenko
A. G. Selezneva
A. S. Fes'kova
S. S. Galetova
N. P. Mironova
author_facet O. A. Lobovikova
I. V. Shul'gina
E. G. Abramova
A. K. Nikiforov
A. V. Komissarov
V. A. Demchenko
A. G. Selezneva
A. S. Fes'kova
S. S. Galetova
N. P. Mironova
author_sort O. A. Lobovikova
collection DOAJ
description Introduction. Documentation is an integral part of the quality management system, a key element of production and quality control of medicines. A necessary condition for the Rules of good manufacturing practice and guaranteed production of quality products is compliance with the requirements set out in the documents of the registration dossier for the drug. During the life cycle of a drug, post-registration changes in the dossier may be required.Text. This work is an analytical review of changes in the documents of the registration dossier for the drug «Immunoglobulin antirabic from horse blood serum liquid», solution for injections, reflecting the improvement of biotechnology of drug production and methods of its control in the post – registration period. The first post-registration changes in the regulatory documentation were administrative in nature and did not require examination of samples of the drug. The next group of changes in the documents of the registration dossier was due to the expansion of production, reconstruction of technological sites and the introduction of innovative technologies in order to comply with the requirements of GMP, as well as improving the consumer properties of the drug. The last group of changes concerned the revision of methods of quality control of finished products associated with the introduction of modern analytical equipment, expanding the list of standards and bringing into compliance with the requirements of the state Pharmacopoeia XIII edition.Conclusion. The timely introduction of changes into documents of the registration dossier allows you to optimize the procedure for the conduct of internal and external control of rabies immunoglobulin, as well as to avoid violations related to the actualization of the technological documentation. The analysis of changes in the documents of the registration dossier for the drug «Immunoglobulin antirabic from horse blood serum liquid», solution for injections, reflecting the improvement of biotechnology of drug production and methods of its control in the post-registration period. Timely changes in the documents of the registration dossier allow to optimize the procedure of internal and external quality control of anti-rabies immunoglobulin, as well as to avoid violations associated with the updating of technological documentation.
first_indexed 2024-04-10T01:40:44Z
format Article
id doaj.art-e2b5b9429fef4aabbb3d8f14e5d50811
institution Directory Open Access Journal
issn 2305-2066
2658-5049
language Russian
last_indexed 2024-04-10T01:40:44Z
publishDate 2019-02-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj.art-e2b5b9429fef4aabbb3d8f14e5d508112023-03-13T09:14:00ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492019-02-0181929610.33380/2305-2066-2019-8-1-92-96653REGISTRATION DOCUMENTATION AND AMENDMENTS TO IT AS AN ELEMENT OF A QUALITY MANAGEMENT SYSTEM IN PRODUCTION OF ANTI-RABIES IMMUNOGLOBULIN (REVIEW)O. A. Lobovikova0I. V. Shul'gina1E. G. Abramova2A. K. Nikiforov3A. V. Komissarov4V. A. Demchenko5A. G. Selezneva6A. S. Fes'kova7S. S. Galetova8N. P. Mironova9ФКУЗ РосНИПЧИ «Микроб» РоспотребнадзораФКУЗ РосНИПЧИ «Микроб» РоспотребнадзораФКУЗ РосНИПЧИ «Микроб» РоспотребнадзораФКУЗ РосНИПЧИ «Микроб» Роспотребнадзора; ФГБОУ ВО «Саратовский государственный аграрный университет имени Н.И. Вавилова»ФКУЗ РосНИПЧИ «Микроб» Роспотребнадзора; ФГБОУ ВО «Саратовский государственный аграрный университет имени Н.И. Вавилова»ФКУЗ РосНИПЧИ «Микроб» РоспотребнадзораФКУЗ РосНИПЧИ «Микроб» РоспотребнадзораФКУЗ РосНИПЧИ «Микроб» РоспотребнадзораФКУЗ РосНИПЧИ «Микроб» РоспотребнадзораФКУЗ РосНИПЧИ «Микроб» РоспотребнадзораIntroduction. Documentation is an integral part of the quality management system, a key element of production and quality control of medicines. A necessary condition for the Rules of good manufacturing practice and guaranteed production of quality products is compliance with the requirements set out in the documents of the registration dossier for the drug. During the life cycle of a drug, post-registration changes in the dossier may be required.Text. This work is an analytical review of changes in the documents of the registration dossier for the drug «Immunoglobulin antirabic from horse blood serum liquid», solution for injections, reflecting the improvement of biotechnology of drug production and methods of its control in the post – registration period. The first post-registration changes in the regulatory documentation were administrative in nature and did not require examination of samples of the drug. The next group of changes in the documents of the registration dossier was due to the expansion of production, reconstruction of technological sites and the introduction of innovative technologies in order to comply with the requirements of GMP, as well as improving the consumer properties of the drug. The last group of changes concerned the revision of methods of quality control of finished products associated with the introduction of modern analytical equipment, expanding the list of standards and bringing into compliance with the requirements of the state Pharmacopoeia XIII edition.Conclusion. The timely introduction of changes into documents of the registration dossier allows you to optimize the procedure for the conduct of internal and external control of rabies immunoglobulin, as well as to avoid violations related to the actualization of the technological documentation. The analysis of changes in the documents of the registration dossier for the drug «Immunoglobulin antirabic from horse blood serum liquid», solution for injections, reflecting the improvement of biotechnology of drug production and methods of its control in the post-registration period. Timely changes in the documents of the registration dossier allow to optimize the procedure of internal and external quality control of anti-rabies immunoglobulin, as well as to avoid violations associated with the updating of technological documentation.https://www.pharmjournal.ru/jour/article/view/653регистрационное досьефармакопейная статья предприятияантирабический иммуноглобулинбиотехнология производстваметоды контроля
spellingShingle O. A. Lobovikova
I. V. Shul'gina
E. G. Abramova
A. K. Nikiforov
A. V. Komissarov
V. A. Demchenko
A. G. Selezneva
A. S. Fes'kova
S. S. Galetova
N. P. Mironova
REGISTRATION DOCUMENTATION AND AMENDMENTS TO IT AS AN ELEMENT OF A QUALITY MANAGEMENT SYSTEM IN PRODUCTION OF ANTI-RABIES IMMUNOGLOBULIN (REVIEW)
Разработка и регистрация лекарственных средств
регистрационное досье
фармакопейная статья предприятия
антирабический иммуноглобулин
биотехнология производства
методы контроля
title REGISTRATION DOCUMENTATION AND AMENDMENTS TO IT AS AN ELEMENT OF A QUALITY MANAGEMENT SYSTEM IN PRODUCTION OF ANTI-RABIES IMMUNOGLOBULIN (REVIEW)
title_full REGISTRATION DOCUMENTATION AND AMENDMENTS TO IT AS AN ELEMENT OF A QUALITY MANAGEMENT SYSTEM IN PRODUCTION OF ANTI-RABIES IMMUNOGLOBULIN (REVIEW)
title_fullStr REGISTRATION DOCUMENTATION AND AMENDMENTS TO IT AS AN ELEMENT OF A QUALITY MANAGEMENT SYSTEM IN PRODUCTION OF ANTI-RABIES IMMUNOGLOBULIN (REVIEW)
title_full_unstemmed REGISTRATION DOCUMENTATION AND AMENDMENTS TO IT AS AN ELEMENT OF A QUALITY MANAGEMENT SYSTEM IN PRODUCTION OF ANTI-RABIES IMMUNOGLOBULIN (REVIEW)
title_short REGISTRATION DOCUMENTATION AND AMENDMENTS TO IT AS AN ELEMENT OF A QUALITY MANAGEMENT SYSTEM IN PRODUCTION OF ANTI-RABIES IMMUNOGLOBULIN (REVIEW)
title_sort registration documentation and amendments to it as an element of a quality management system in production of anti rabies immunoglobulin review
topic регистрационное досье
фармакопейная статья предприятия
антирабический иммуноглобулин
биотехнология производства
методы контроля
url https://www.pharmjournal.ru/jour/article/view/653
work_keys_str_mv AT oalobovikova registrationdocumentationandamendmentstoitasanelementofaqualitymanagementsysteminproductionofantirabiesimmunoglobulinreview
AT ivshulgina registrationdocumentationandamendmentstoitasanelementofaqualitymanagementsysteminproductionofantirabiesimmunoglobulinreview
AT egabramova registrationdocumentationandamendmentstoitasanelementofaqualitymanagementsysteminproductionofantirabiesimmunoglobulinreview
AT aknikiforov registrationdocumentationandamendmentstoitasanelementofaqualitymanagementsysteminproductionofantirabiesimmunoglobulinreview
AT avkomissarov registrationdocumentationandamendmentstoitasanelementofaqualitymanagementsysteminproductionofantirabiesimmunoglobulinreview
AT vademchenko registrationdocumentationandamendmentstoitasanelementofaqualitymanagementsysteminproductionofantirabiesimmunoglobulinreview
AT agselezneva registrationdocumentationandamendmentstoitasanelementofaqualitymanagementsysteminproductionofantirabiesimmunoglobulinreview
AT asfeskova registrationdocumentationandamendmentstoitasanelementofaqualitymanagementsysteminproductionofantirabiesimmunoglobulinreview
AT ssgaletova registrationdocumentationandamendmentstoitasanelementofaqualitymanagementsysteminproductionofantirabiesimmunoglobulinreview
AT npmironova registrationdocumentationandamendmentstoitasanelementofaqualitymanagementsysteminproductionofantirabiesimmunoglobulinreview